Bioventus Inc - Ordinary Shares - Class A

-0.15 (-4.89%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)183.35M
Current PEN/A
Forward PE N/A
2yr Forward PE 10.07
See more stats
Estimates Current Quarter
Revenue$119 Million
Adjusted EPS-$0.02
See more estimates
10-Day MA$3.12
50-Day MA$3.61
200-Day MA$2.44
See more pivots

Bioventus Inc - Ordinary Shares - Class A Stock, NASDAQ:BVS

4721 Emperor Boulevard, Suite 100, Durham, North Carolina 27703
United States of America
Phone: +1.919.474.6700
Number of Employees: 1120


Bioventus, Inc. is a medical technology company, which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. It operates through the following business segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP. The Active Healing Therapies-U.S and International offers two types of non-surgical products which are non-invasive exogen system for long bone stimulation for fracture healing and hyaluronic acid, or HA, viscosupplementation therapies for osteoarthritis pain relief. The Surgical segment offers a portfolio of advanced bone graft substitutes. The BMP segment comprises proprietary next-generation bone morphogenetic protein, or BMP. The company was founded on November 23, 2011 and is headquartered in Durham, NC.